Literature DB >> 20872094

Association of apolipoprotein M gene polymorphisms with ischemic stroke in a Han Chinese population.

Dongxue Zhao1, Zhiyi He, Xue Qin, Lei Li, Fang Liu, Shumin Deng.   

Abstract

The apolipoprotein M (ApoM) gene is critical in the formation of pre-β-high-density lipoprotein (HDL) and cholesterol efflux to HDL. In this case and control study, 314 ischemic stroke patients and 389 healthy controls were analyzed for three ApoM gene single-nucleotide polymorphisms (SNPs), i.e., C-1065A, T-855C, and T-778C, using a SNaPshot Multiplex sequencing assay. The genotype and allele frequencies of the T-855C were similar in both ischemic stroke patients and the controls. But the frequency of the TC genotype, the C allele of T-778C, and the A allele of the C-1065A SNPs in ischemic stroke patients was significantly higher than that of the healthy controls. After adjusting for confounding risk factors (such as hypertension, diabetes, tobacco smoking, and alcohol consumption), the ApoM gene TC genotype, C allele of T-778C, and A allele of C-1065A were associated with a risk of ischemic stroke. Moreover, plasma levels of total cholesterol were significantly higher in patients with CC or CT genotypes of T-778C than those with TT genotype in the controls. The current data demonstrated that ApoM T-778 C and C-1065A SNPs were associated with increased risk of ischemic stroke in this Han Chinese population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20872094     DOI: 10.1007/s12031-010-9453-7

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  24 in total

1.  A novel human apolipoprotein (apoM).

Authors:  N Xu; B Dahlbäck
Journal:  J Biol Chem       Date:  1999-10-29       Impact factor: 5.157

2.  Analysis of the gene-dense major histocompatibility complex class III region and its comparison to mouse.

Authors:  Tao Xie; Lee Rowen; Begoña Aguado; Mary Ellen Ahearn; Anup Madan; Shizhen Qin; R Duncan Campbell; Leroy Hood
Journal:  Genome Res       Date:  2003-12       Impact factor: 9.043

3.  A rapid procedure for extracting genomic DNA from leukocytes.

Authors:  S W John; G Weitzner; R Rozen; C R Scriver
Journal:  Nucleic Acids Res       Date:  1991-01-25       Impact factor: 16.971

4.  A prospective evaluation of apolipoprotein M gene T-778C polymorphism in relation to coronary artery disease in Han Chinese.

Authors:  Guo-qing Jiao; Zhong-xiang Yuan; Yong-sheng Xue; Cheng-jian Yang; Cheng-bao Lu; Zhi-qian Lu; Ming-di Xiao
Journal:  Clin Biochem       Date:  2007-07-04       Impact factor: 3.281

5.  Isolation and characterization of human apolipoprotein M-containing lipoproteins.

Authors:  Christina Christoffersen; Lars Bo Nielsen; Olof Axler; Astra Andersson; Anders H Johnsen; Björn Dahlbäck
Journal:  J Lipid Res       Date:  2006-05-08       Impact factor: 5.922

6.  Specific tissue expression and cellular localization of human apolipoprotein M as determined by in situ hybridization.

Authors:  Xiao-Ying Zhang; Xuan Dong; Lu Zheng; Guang-Hua Luo; Yuan-Hua Liu; Ulf Ekström; Peter Nilsson-Ehle; Qing Ye; Ning Xu
Journal:  Acta Histochem       Date:  2003       Impact factor: 2.479

7.  Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells.

Authors:  Ning Xu; Xiao-Ying Zhang; Xuan Dong; Ulf Ekström; Qing Ye; Peter Nilsson-Ehle
Journal:  Biochem Biophys Res Commun       Date:  2002-04-12       Impact factor: 3.575

8.  Interaction of angiotensin-converting enzyme and apolipoprotein E gene polymorphisms in ischemic stroke involving large-vessel disease.

Authors:  Sarra Saidi; Walid Zammiti; Lamia B Slamia; Sofyan B Ammou; Wassim Y Almawi; Touhami Mahjoub
Journal:  J Thromb Thrombolysis       Date:  2007-11-21       Impact factor: 2.300

9.  Transforming growth factor-beta down-regulates apolipoprotein M in HepG2 cells.

Authors:  Ning Xu; Maria Hurtig; Xiao-Ying Zhang; Qing Ye; Peter Nilsson-Ehle
Journal:  Biochim Biophys Acta       Date:  2004-07-05

10.  Correlation of apolipoprotein M with leptin and cholesterol in normal and obese subjects.

Authors:  Ning Xu; Peter Nilsson-Ehle; Bo Ahrén
Journal:  J Nutr Biochem       Date:  2004-10       Impact factor: 6.048

View more
  6 in total

1.  Triglyceride level-influencing functional variants of the ANGPTL3, CILP2, and TRIB1 loci in ischemic stroke.

Authors:  Luca Járomi; Veronika Csöngei; Noémi Polgár; Gábor Rappai; Zoltán Szolnoki; Anita Maász; Katalin Horvatovich; Eniko Sáfrány; Csilla Sipeky; Lili Magyari; Béla Melegh
Journal:  Neuromolecular Med       Date:  2011-06-21       Impact factor: 3.843

2.  Association of ALOX15 gene polymorphism with ischemic stroke in Northern Chinese Han population.

Authors:  Jie Zhao; Zhiyi He; Shanshan Ma; Lei Li
Journal:  J Mol Neurosci       Date:  2012-02-19       Impact factor: 3.444

3.  Apolipoprotein M gene (APOM) polymorphism modifies metabolic and disease traits in type 2 diabetes.

Authors:  Jun-Wei Zhou; Stephen K W Tsui; Maggie C Y Ng; Hua Geng; Sai-Kam Li; Wing-Yee So; Ronald C Ma; Ying Wang; Qian Tao; Zhen-Yu Chen; Juliana C N Chan; Yuan-Yuan Ho
Journal:  PLoS One       Date:  2011-02-24       Impact factor: 3.240

4.  Meta-Analysis on the Correlation Between APOM rs805296 Polymorphism and Risk of Coronary Artery Disease.

Authors:  HongYan Sun; Dong Shen; ChunHong Zhang; DangSheng Huang; YuMei Wang; LiWei Zhang
Journal:  Med Sci Monit       Date:  2016-01-02

5.  Low apolipoprotein M serum levels correlate with Systemic lupus erythematosus disease activity and apolipoprotein M gene polymorphisms with Lupus.

Authors:  Wenhan Du; Ting Shen; Hui Li; Yinyin Liu; Lagu He; Li Tan; Min Hu; Yaping Ren
Journal:  Lipids Health Dis       Date:  2017-05-05       Impact factor: 3.876

6.  Apolipoprotein M T-778C polymorphism is associated with serum lipid levels and the risk of coronary artery disease in the Chinese population: a meta-analysis.

Authors:  Zhi Zhang; Guang Chu; Rui-Xing Yin
Journal:  Lipids Health Dis       Date:  2013-09-16       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.